BioSpace News Archive

Partnership is part of MetaBank’s continued investment in consumer lending via its total solution platform for marketplace lending

DURATION-7 study results showed significant HbA1c reduction when BYDUREON was added to insulin glargine therapy vs insulin glargine alone

Initial Stocking Order Received from Dar Al Zahrawi Medical Co LLC, KSA

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announces the Company has retained PAREXEL® (www.parexel.com/) to assist in preparing and presenting the Biologics License Application (BLA) for Ampion™ for the treatment of osteoarthritis-of-the-knee (OAK) to the FDA.

Patent covers uses of recombinant compounds with at least two human IgG1 Fc domains that bind receptors found on immune cells

William R. LaRue and Charles Theuer, M.D., Ph.D., Bring Broad Experience in Executive Leadership, Corporate Finance and Oncology Drug Development

Allogene intends to assume from Pfizer the global strategic collaboration agreement originally formed with Cellectis in 2014

LONHALA MAGNAIR is the first nebulized long-acting muscarinic antagonist (LAMA) available for the treatment of COPD in the U.S.

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or patients with locally advanced CSCC who are not candidates for surgery.